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Abstract
We report a 32-year-old woman (1-gravid, 1-para) with a vesicular lesion in her uterus that was pointed out on
ultrasound at 8 weeks’ gestation. Amniocentesis at 15 weeks’ gestation showed a normal female karyotype, 46XX.
As the pregnancy advanced, the mole-like lesion became relatively reduced. Throughout gestation, the maternal
human chorionic gonadotropin level was normal, but the serum alpha fetoprotein level rose as her pregnancy
progressed. Her fetus did not exhibit any remarkable anomalies. The patient visited our hospital complaining of a
diminished feeling of fetal movements at 36 weeks 5 days’ gestation, and intrauterine fetal death (IUFD) was
confirmed. She delivered a 2336-g female without any definite anomalies. A pathological examination led to a
diagnosis of placental mesenchymal dysplasia, and androgenetic/biparental mosaicism in the placenta was
identified using p57
kip2 immunohistochemical staining. And it also revealed that the rupture of the cirsoid
chorionic vessels had led to IUFD.
Background
Placental mesenchymal dysplasia (PMD) is a rare placen-
tal anomaly characterized by placentomegaly and grape-
like vesicles resembling molar pregnancy. The incidence
of PMD is reportedly 0.02% [1], with a definite prepon-
derance of females [2]. Distinguishing PMD from its
mimics, especially molar pregnancy is important for pre-
venting the unnecessary termination of pregnancy.
Unlike molar pregnancies, PMD usually features a nor-
mal fetus. However, PMD is distinct in that it has a high
incidence of fetal growth restriction (FGR) and intrauter-
ine fetal death (IUFD), and is associated with Beckwith-
Wiedemann syndrome (BWS), a condition characterized
by macrosomia, visceromegaly, macroglossia, and
omphalocele [2]. Pathologically, PMD placentas are
usually large size, and show edema of stem villi with
intact terminal villi and many kinds of vascular anoma-
lies, such as cirsoid chorionic vessels, thrombosis, thick-
ness of vessel wall, vascular stenosis, villous chorangiosis,
chorioangioma and fetal thrombotic vasculopathy. Also
abnormal umbilical cords, including tortuous, marked
twisted cords, excessively long cords, etc. [2,3]. These
vascular anomalies may lead to FGR and IUFD. Absence
of trophoblastic proliferation in PMD placentas is a his-
tological difference from partial moles [4]. Although the
pathogenesis of PMD remains unknown, androgenetic/
biparental mosaicism has recently been suggested as the
underlying cause of PMD [5]. The phenotypic features of
PMD, including the absence of trophoblastic hyperplasia,
its association with BWS, and its female preponderance,
can all be explained by this novel mechanism. We report
a new case of PMD without BWS, but intrauterine sud-
den death of the fetus without any anomaly contained
FGR, at 36 weeks’ gestation.
Case presentation
A 32-year old woman, gravid 1, para 1, began visiting
our hospital at 4 weeks’ gestation. An ultrasound per-
formed at 8 weeks’ gestation as part of a routine prena-
tal checkup detected a vesicular lesion in her uterus
(Figure 1). The maternal hCG level at 12 weeks’ gesta-
tion was 100,614 mIU/mL, and this level remained
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serum alpha-fetoprotein level increased as her preg-
nancy progressed, reaching 879 ng/mL at 33 weeks’
gestation (2.7 multiples of the median; normal medians
referenced from previous report [6]). An amniocentesis
p e r f o r m e da t1 5w e e k s ’ gestation showed a normal
female karyotype, 46XX. As the pregnancy advanced,
the vesicular lesion decreased in size and no fetal
abnormalities were detected. At 33 weeks’ gestation,
however, an ultrasound detected dilated chorionic ves-
sels (Figure 2). The patient visited our hospital com-
plaining of a diminished feeling of fetal movements at
36 weeks 5 days of gestation, and IUFD was confirmed.
She delivered a 2336 g female without any definite
Figure 1 Transvaginal ultrasound study. An apparently normal fetus (asterisk) and villi with multiple hypoechoic cysts (arrows) at 8 weeks’
gestation. Crown-rump length is 20 millimeters. Each cyst is 2-3 millimeters in diameter.
Figure 2 Transabdominal ultrasound study. Placental parenchyma (asterisk) and dilated subchorionic vessels (arrows) at 35 weeks’ gestation.
These vessels are up to 2.5 centimeters in diameter.
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was 18 centimeters in diameter and weighed 720 g, and
a long umbilical cord (about 70 cm) was found. The
chorionic vessels were cirsoid, dilated and tortuous (Fig-
ure 3a). A cross section of the placenta showed the for-
mation of a hematoma bordering on the dilated
chorionic plate vessels and vesicular changes in one-
third of the parenchyma (Figure 3b). A histological
examination revealed that the cirsoid dilated chorionic
vessels were fragile, that a portion of the smooth
muscles of the vessel had disappeared, and that the ves-
sel wall was ruptured, causing a hemorrhage with hema-
toma formation (Figure 4). Hydropic stem villi and
diminished vessels were observed in the affected lesion
of the placenta. These changes were more clearly shown
by immunohistochemical staining with CD34, resulting
in the positive staining of vascular endothelium (Figure
5a and 5b). Although almost of the terminal villi were
not affected, fetal thrombotic vasculopathy was seen in a
part of the affected lesion (Figure 5c and 5d).
Figure 3 Fetal surface and cross-section of the placenta. a) Dilated and tortuous chorionic vessels and an excessively long umbilical cord. b)
The formation of a hematoma bordering the dilated chorionic plate vessels and vesicular changes in the parenchyma (arrows).
Figure 4 Merged photographs of a dilated chorionic plate vessel. The smooth muscle of the dilated chorionic plate vessel has disappeared
(arrow), and the vessel wall has ruptured, producing hemorrhage and the formation of a hematoma (asterisk). (hematoxylin-eosin staining (HE),
objective ×1).
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kip2 gene, which encodes a cyclin-dependent
kinase inhibitor, is expressed in the maternal genome,
whereas the paternal allele is transcriptionally silent [7].
Immunohistochemical staining of p57
kip2 showed that
some villi were composed of stromal cells that were
negative for p57
kip2 only in the affected lesion (Figure 6a
and 6b). Therefore, the villi of the affected lesion formed
a mosaic of biparental and androgenetic cell popula-
tions. These pathological findings led to a diagnosis of
PMD.
Discussion
The main differential diagnoses of PMD are partial
hydatidiform mole, dichorionic twins of a normal fetus
and complete mole, and confined placental mosaicism.
When a prenatal ultrasonographic examination detects a
vesicular lesion in the presence of a fetus in uterus,
whether a single or twin pregnancy is present should be
determined. A twin pregnancy would consist of dichor-
ionic twins of a normal fetus and complete mole. In the
present case, ultrasound appeared to reveal a single
pregnancy. Unlike partial moles, the majority of PMD
are diploid [8]. In 70 - 80% of cases, the partial moles
are triploid, often with 2 sets of paternal genes and 1 set
of maternal genes as a result of dispermy fertilization
[9]. Cases of confined placental mosaicism involving
trisomy 16 have been reported as exhibiting cystic villi
on ultrasound, but these cases can be diagnosed accu-
rately by karyotyping [10]. In the present case, an
amniocentesis performed at 15 weeks’ gestation showed
a normal female karyotype, 46XX. The characteristic
laboratory test for PMD includes an increased level of
maternal serum AFP. The increase in the surface trans-
fer area as a result of the increased placental volume
Figure 5 Histopathology and immunohistochemistry of abnormal villi. a) Hydropic stem villi and diminished vessels at the affected lesion
of the placenta. (HE, objective ×4). The lower left empty corner shows a cystic cavity of the hydropic stem villus. b) Decrease in both number
and size of vessels by the CD34 immunohistochemical staining. (objective ×4). c) Avascular terminal villi in a part of the affected area. (HE,
objective ×10). d) Scatter and disappearance of immunohistochemical CD34-positive endothelial cells in the avascular terminal villi (objective
×20).
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is thought to lead to an increased transfer of AFP into
the maternal circulation [4]. On the other hand, unlike
with moles, the level of hCG in patients with PMD is
normal to slightly increased throughout gestation [11].
In this case, although the maternal hCG level was nor-
mal throughout gestation, the serum AFP level increased
as her pregnancy progressed. These prenatal findings
suggested a diagnosis of PMD.
The placenta is usually extremely large for the gesta-
tional age and the umbilical cord is relatively long in
cases with PMD [2,3]. The gross placental findings for
PMD vary with gestational age. To our knowledge, no
previous report has detected a vesicular lesion in a
patient with PMD prior to 13 weeks’ gestation. In the
present case, a vesicular lesion was detected at 8 weeks’
gestation. Thus, the morphological changes in the villi
appear to begin early during gestation. During the third
trimester, the chorionic plate vessels in a PMD placenta
are aneurysmally dilated and tortuous [11]. However, in
cases terminated before 20 weeks of gestation, the chor-
ionic plate vessels are not dilated, and the normal and
abnormal areas are not clearly delineated, suggesting
that the vascular malformations develop progressively
[12]. As the pregnancy advances, tangled congested ves-
sels grossly resembling gray-white or dark-red wormlike
structures may be identified within the parenchyma and
are often most prominent in the subchorionic plate
region near the fetal surface [8]. An ultrasound per-
formed at 33 weeks’ gestation seemingly detected this
finding (Figure 2).
Although morphologic gross findings of PMD placen-
tas are so often mimicked by features of partial hydatidi-
form moles, PMD placentas are markedly enlarged and
macroscopic vascular anomalies such as cirsoid dilated
chorionic vessels with or without thrombi and umbilical
cord anomalies like a long umbilical cord that were
observed in our case are often co-existence in PMD pla-
centas, but they are not usual in molar pregnancies
[2,13]. Microscopically, PMD placentas typically reveal
large stem villi with hydropic swelling and cistern for-
mation interspersed with unaffected terminal villi. Simi-
larly, mixture of hydropic villi with cistern formation
and unaffected villi are also found in partial hydatidi-
form moles, however, trophoblastic stromal inclusions
and proliferations, which are absent in PMD placentas,
are also characteristic of molar pregnancies. Not only
macroscopic but also microscopic vascular anomalies
such as fetal thrombotic vasculopathy that was found in
our case, villous chorangiosis and chorangioma, are also
characteristic together hydropic villi in PMD placentas,
but not in molar pregnancies [2,3,13]. These morpholo-
gical characteristics of PMD placenta supported to diag-
nose our case as PMD. Immunohistochemistry using
antibodies against products of paternal imprinting genes
such as the antibody against p57
kip2 protein is a poten-
tial marker that may prove helpful in distinguishing
PMD from molar pregnancy. The immunohistochemical
detection of androgenetic/biparental mosaicism in stro-
mal cells suggests to a diagnosis of PMD, because this
mosaicism is unusual in molar pregnancies [14]. Dichor-
ionic twin placentas with a normal fetus and complete
mole may also be needed to pathologically distinguish
to PMD. But, vascular anomalies seen in PMD placentas
are absent in their placentas and complete moles are
purely androgenetic. Spontaneous abortion with hydro-
p i cc h a n g em a yh a v ev e s i c l ef o r m a t i o na n dc a na l s ob e
confused with early PMD, however, the vesicles, if
Figure 6 Androgenetic/biparental mosaicism detected by p57
kip2 immunohistochemical staining in the affected lesion.p 5 7
kip2-positive
stromal cells indicate biparental villi in a, and no p57
kip2-positive stromal cell in some villi (asterisks) suggests androgenetic villi in b. (objective ×10).
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shows degenerative changes [3].
PMD has distinct clinicopathological features. Accord-
ing to Truc et al. [2], 82% of the affected fetuses are
female and about 20% of cases with PMD also have BWS.
Among the PMD cases without BWS, the FGR and the
IUFD rate are 50% and 36%, respectively. IUFD can
occur throughout gestation (before 21 weeks, 14.3%;
22~27 weeks, 23.8%; 28~33 weeks, 33.3%; after 34 weeks,
28.6%). The cause of IUFD is currently unclear and may
be heterogeneous. Thrombosis of chorionic vessels and
umbilical cord anomalies are thought to be likely causes
of IUFD in PMD cases, and Truc et al. reported that
IUFD may be explained by a potentially chronic hypoxia
secondary to obstructive fetal vascular thrombosis and a
decrease in maternal-fetal gas exchange as a result of an
insufficient amount of normal chorionic villi and the
shunting of blood from the exchange surface in chorioan-
giomas and dysplastic villi [2]. In our case, histological
examination revealed that the dilated cirsoid chorionic
vessels were fragile and that part of the vessel wall had
ruptured, resulting in hemorrhage with hematoma for-
mation. Although fetal thrombotic vasculopathy was
found in a part of the affected lesion, this hemorrhage
was thought to have led to sudden death of the fetus at
the late gestational age (36 weeks 5 days) because no sig-
nificant chronic hypoxic anomaly of the fetus including
FGR was observed.
The underlying cause of PMD is currently unknown.
Recently, Kaiser-Rogers et al. proposed androgenetic/
biparental mosaicism as the origin of some cases of
PMD and suggested that the phenotype of androgenetic
mosaicism can presumably range from mild PMD,
which may not even be diagnosed, to the typical find-
ings of a complete hydatidiform mole, depending on the
extent and distribution of the androgenetic lineage [5].
The authors hypothesized that such mosaicism arose as
the result of a failure in the replication of the maternal
genome prior to the first cleavage, with normal replica-
tion and segregation of the paternal genome, resulting
in two types of daughter cells, one with normal biparen-
tal genes and the other with only paternal genes. Such
failed division would produce a diploid/haploid mosaic
embryo, and endoreduplication of the haploid paternal-
only daughter cell could then occur to produce the
diploid androgenetic lineage, while the female and male
haploid complements would merge to form a daughter
cell with normal biparental inheritance. The phenotypic
features of PMD, including the preponderance of
females, the absence of trophoblastic hyperplasia, and
the association with BWS, can all be explained by this
mechanism. Since an androgenic 46, YY cell line would
be nonviable, PMD cases would show the marked
female predominance. The abnormal androgenetic cells
would be confined to the chorionic mesoderm, mem-
branes, and vessels, whereas the trophoblastic cells
would be normal with no evidence of androgenetic cells
[5]. This feature would explain the absence of tropho-
blast overgrowth in PMD in contrast to complete moles,
in which androgenetic cells are identified in the tropho-
blastic cell layer. BWS is a condition of constitutional
overgrowth with genetic linkage to chromosome
11p15.5. [15]. Insulin-like growth factor-2 is located in
this lesion, and the maternal allele is normally sup-
pressed so that only the paternal gene is expressed.
Thus, the loss of 11p15.5. gene imprinting could lead to
PMD in some cases.
Conclusions
PMD should be included in a differential diagnosis of
cystic lesions of the placenta by sonography, especially
when a phenotypically normal-appearing fetus can be
identified. When the prenatal characteristics of PMD,
such as an elevated AFP and normal hCG level in the
mother, a normal female karyotype revealed by amnio-
centesis, and dilated subchorionic vessels revealed by
ultrasonography during the third trimester, are detected,
termination of the pregnancy at an optimal time could
be considered, since sudden IUFD including rupture of
the cirsoid chorionic vessels might occur at any time
throughout gestation.
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